Vinorelbine trials for Breast cancer

All Vinorelbine trials · All Breast cancer trials

Phase breakdown

Recruiting trials studying Vinorelbine for Breast cancer

• A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer
  NCT06435429 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 166 locations
• ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
  NCT07007559 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 54 locations
• Organoid-based Functional Precision Therapy for Advanced Breast Cancer
  NCT06102824 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Patient Derived Organoid-guided Personalized Treatment Versus Treatment of Physician's Choice in Breast Cancer
  NCT06268652 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Study of SKB264 for Locally Advanced, Recurrent or Metastatic HR+/HER2- Breast Cancer
  NCT06081959 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• YL202 Versus Treatment of Physician's Choice in Patients With HR+/HER2- Breast Cancer
  NCT07461454 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: Female · 1 location

Common questions

How many trials study Vinorelbine for Breast cancer?

6 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.